8-KThe WireStrategic
Results of Operations
Filed May 12, 2026 · 2mo ago · Accession 0001193125-26-218134
Plain English
CalciMedica, Inc. reported its financial results for the fiscal quarter ended March 31, 2026, and provided updates on its clinical programs. The company announced that FDA feedback on the Auxora™ pivotal program in acute pancreatitis and potential future development in acute kidney injury is expected in 2Q 2026.
Filing details
- Company
- CalciMedica, Inc.
- Ticker
- CALC
- CIK
- 1534133
- Form type
- 8-K
- Filing date
- May 12, 2026
- Report date
- May 12, 2026
- Document
- ck0001534133-20260512.htm
- Size
- 390 KB